Nonspecific medication side effects and the nocebo phenomenon.
暂无分享,去创建一个
[1] C. Larousse,et al. Methodology and results of a survey of adverse reactions to a drug in private practice , 1977, European Journal of Clinical Pharmacology.
[2] Y. Maugars,et al. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. , 2001, Joint, bone, spine : revue du rhumatisme.
[3] G. Tollefson,et al. No gender differences in placebo responses of patients with major depressive disorder , 2001, Biological Psychiatry.
[4] A. Ströhle. Increased response to a putative panicogenic nocebo administration in female patients with panic disorder. , 2000, Journal of psychiatric research.
[5] D. Reda,et al. Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study. , 2000, Archives of internal medicine.
[6] L. Balant,et al. Cultural differences: implications on drug therapy and global drug development. , 2000, International journal of clinical pharmacology and therapeutics.
[7] Kay Brune,et al. Incidence and Costs of Adverse Drug Reactions During Hospitalisation , 2000, Drug safety.
[8] Rawlins,et al. Attitudinal survey of voluntary reporting of adverse drug reactions. , 1999, British journal of clinical pharmacology.
[9] M. Liang,et al. Somatic style and symptom reporting in rheumatoid arthritis. , 1999, Psychosomatics.
[10] A. Barsky,et al. Functional Somatic Syndromes , 1999, Annals of Internal Medicine.
[11] Anne Harrington,et al. The Placebo Effect: An Interdisciplinary Exploration , 1999 .
[12] M. Flaten,et al. Drug-related information generates placebo and nocebo responses that modify the drug response. , 1999, Psychosomatic medicine.
[13] N. Moore,et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. , 1998, British journal of clinical pharmacology.
[14] E. Uhlenhuth,et al. Medication side effects in anxious patients: negative placebo responses? , 1998, Journal of affective disorders.
[15] R. Hahn,et al. The nocebo phenomenon: concept, evidence, and implications for public health. , 1997, Preventive medicine.
[16] K. Waterloo,et al. Pharmacological classical conditioning in humans , 1997 .
[17] Fabrizio Benedetti,et al. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide , 1997, Pain.
[18] J. Kleijnen,et al. Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness , 1996, BMJ.
[19] S. von Ammon Cavanaugh,et al. Placebo effects. Issues for clinical practice in psychiatry and medicine. , 1996, Psychosomatics.
[20] J. A. Johnson,et al. Drug-Related Morbidity and Mortality: A Cost-of-Illness Model , 1995 .
[21] S. Kennedy,et al. The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. , 1995, Journal of clinical psychopharmacology.
[22] M. Drici,et al. Influence of the behaviour pattern on the nocebo response of healthy volunteers. , 1995, British journal of clinical pharmacology.
[23] D. Mj,et al. Adverse reactions to drugs in a health center , 1994 .
[24] W. Helsel,et al. Risk factors for the development of placebo adverse reactions in a multicenter clinical trial. , 1994, Annals of epidemiology.
[25] R A Deyo,et al. The importance of placebo effects in pain treatment and research. , 1994, JAMA.
[26] S. Dworkin,et al. Somatization and pain dispersion in chronic temporomandibular disorder pain , 1994, Pain.
[27] P. Leaverton,et al. Scientific and ethical issues in the use of placebo controls in clinical trials. , 1994, Annual review of public health.
[28] L. Passman,et al. The treatment of mild hypertension study. , 1993, JAMA.
[29] E. Nelson,et al. The treatment of mild hypertension study. , 1993, JAMA.
[30] E H Wagner,et al. Patterns of antidepressant use in community practice. , 1993, General hospital psychiatry.
[31] P. Rosenzweig,et al. The placebo effect in healthy volunteers: Influence of experimental conditions on the adverse events profile during phase I studies , 1993, Clinical pharmacology and therapeutics.
[32] J. Ferguson. Alprazolam-XR: Patient Acceptability, Safety, and Tolerability , 1993, Psychiatric Annals.
[33] M. Shepherd,et al. The placebo: from specificity to the non-specific and back , 1993, Psychological Medicine.
[34] T R Einarson,et al. Drug-Related Hospital Admissions , 1993, The Annals of pharmacotherapy.
[35] P. Lees-Haley,et al. Biases in Perception and Reporting following a Perceived Toxic Exposure , 1992, Perceptual and motor skills.
[36] V. K. Bajaj,et al. Background noise in healthy volunteers--a consideration in adverse drug reaction studies. , 1992, Indian journal of physiology and pharmacology.
[37] O. Sortland,et al. Iopentol in Urography , 1992 .
[38] O. Sortland,et al. Iopentol in urography. A clinical comparison between iopentol and metrizoate including delayed reactions. , 1992, Acta radiologica.
[39] Wayne Katon,et al. Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.
[40] M. Stockton,et al. Allergy to penicillin: fable or fact? , 1991, BMJ.
[41] N. Cutler,et al. Idioventricular Rhythm: Hypervagotonia Associated with Placebo , 1991, DICP : the annals of pharmacotherapy.
[42] G. Fein,et al. A double-blind study of symptom provocation to determine food sensitivity. , 1990, The New England journal of medicine.
[43] N. Col,et al. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.
[44] D. Long,et al. Placebo responses to medical device therapy for pain. , 1989, Stereotactic and functional neurosurgery.
[45] J. Holland,et al. Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer , 1988, Cancer.
[46] G. Hedlin,et al. Penicillin allergy--a rare paediatric condition? , 1988, Archives of disease in childhood.
[47] A health study of two communities near the Stringfellow Waste Disposal site. , 1988, Archives of environmental health.
[48] C. A. Hart,et al. Gas gangrene: a cautionary tale , 1988, British medical journal.
[49] P. Dobkin,et al. Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: Prevalence, etiology, and behavioral interventions☆ , 1988 .
[50] J Singer,et al. The consent form as a possible cause of side effects , 1987, Clinical pharmacology and therapeutics.
[51] M. Weir,et al. Attitudes to adverse drug reactions and their reporting among medical practitioners. , 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[52] M. Andrykowski,et al. Longitudinal analysis of the development of anticipatory nausea. , 1987, Journal of consulting and clinical psychology.
[53] H. Sørensen,et al. Is type I penicillin allergy overdiagnosed in children? , 1986, Scandinavian journal of primary health care.
[54] L. J. Reed,et al. Community exposure to hazardous waste disposal sites: assessing reporting bias. , 1985, American journal of epidemiology.
[55] A. Barsky. Nonpharmacologic aspects of medication. , 1983, Archives of internal medicine.
[56] N. Oswald. Penicillin allergy: a suspect label. , 1983, British medical journal.
[57] L. W. Buckalew,et al. An Investigation of Drug Expectancy as a Function of Capsule Color and Size and Preparation Form , 1982, Journal of clinical psychopharmacology.
[58] James W. Pennebaker,et al. The psychology of physical symptoms , 1982 .
[59] A. Schweiger,et al. Nocebo: The psychologic induction of pain , 1981, The Pavlovian journal of biological science.
[60] S. Siegel. Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model. , 1976, Science.
[61] C. Buncher,et al. Demonstration to medical students of placebo responses and non-drug factors. , 1972, Lancet.
[62] T. Luparello,et al. The Interaction of Psychologic Stimuli and Pharmacologic Agents on Airway Reactivity in Asthmatic Subjects , 1970, Psychosomatic medicine.
[63] S. Garattini,et al. Monosodium Glutamate and the Chinese Restaurant Syndrome , 1970, Nature.
[64] D. Mcnair,et al. Drug-personality interaction in intensive outpatient treatment. , 1970, Archives of general psychiatry.
[65] J. Cleobury. Adverse Non-drug Reactions , 1969 .
[66] E. R. Mcfadden,et al. The Mechanism of Action of Suggestion in the Induction of Acute Asthma Attacks , 1969, Psychosomatic medicine.
[67] E. R. Mcfadden,et al. Influences of Suggestion on Airway Reactivity in Asthmatic Subjects , 1968, Psychosomatic medicine.
[68] D. Lowenthal,et al. Adverse nondrug reactions. , 1968, The New England journal of medicine.
[69] P. Kissel,et al. Placebos et Effet Placebo en Medecine , 1965 .
[70] Pogge Rc. The toxic placebo. II. The case of the partial patient. , 1963 .
[71] R. Pogge. The toxic placebo. II. The case of the partial patient. , 1963, Medical times.
[72] Kennedy Wp. The nocebo reaction. , 1961 .
[73] E. Kast,et al. Influence of the doctor-patient relationship on drug action. , 1961, The Illinois medical journal.
[74] W. Kennedy. The nocebo reaction. , 1961, Medical world.
[75] C. Joyce. Consistent differences in individual reactions to drugs and dummies. , 1959, British journal of pharmacology and chemotherapy.
[76] J. Groen,et al. Reproducible psychogenic attacks of asthma; a laboratory study. , 1956, Journal of psychosomatic research.
[77] S. Wolf,et al. Effects of placebo administration and occurrence of toxic reactions. , 1954, Journal of the American Medical Association.